Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Cancer Health Center

Font Size

Will Cancer Spread? New Test May Tell

Errant Protein Marks Tumors That Metastasize
WebMD Health News
Reviewed by Laura J. Martin, MD

Feb. 1, 2011 -- A new test appears to predict whether or not cancer will spread to other parts of the body.

The test is a long way from doctors' offices. But in early studies, it has about a 90% success rate in predicting whether a cancer will spread within two years.

The new test is based on an errant protein found in cancers that metastasize -- that is, send out tumor cells that travel to distant parts of the body where they grow into new tumors. The protein is called CPE-deltaN, says senior investigator Y. Peng Loh, PhD.

"By measuring CPE-deltaN or its RNA in a tumor, we can tell two things: whether the tumor already has spread, and whether the tumor is likely to recur or spread," Loh said at a news teleconference held to announce the findings.

Loh and colleagues studied two very different tumor types: liver cancer and rare adrenal cancers. The test worked in both tumor types, suggesting that it may apply to many different kinds of cancer.

Predicting Cancer Spread

A tumor is bad enough in the place where it starts. But cancers that stay in one place often can be surgically removed (resected), usually with a high cure rate.

Metastatic cancer is another story. In a process still not fully understood, tumor cells leave the original (primary) tumor and spread to other places in the body. The tumor cells may fight their way through body tissues into the bloodstream or lymphatic system. These metastases may spread cancer to several sites in the body.

Doctors can't tell which cancers will spread and which will not. It's often not even possible to tell what stage of cancer a person has until the primary tumor is resected and examined.

The current test, if validated in large numbers of patients with different kinds of cancer, could change that, says study researcher Steven Hewitt, MD, PhD, of the National Cancer Institute's Advanced Technology Center.

"We were able to beat the current standard of care for determining the stage and grade of cancers," Hewitt said at the news conference. "Tests such as this, which we can perform on a small tumor sample without full resection, allows doctors to better plan patient care."

Today on WebMD

Colorectal cancer cells
New! I AM Not Cancer Facebook Group
Lung cancer xray
See it in pictures, plus read the facts.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Real Cancer Perspectives
Jennifer Goodman Linn self-portrait
what is your cancer risk
colorectal cancer treatment advances
breast cancer overview slideshow
prostate cancer overview
lung cancer overview slideshow
ovarian cancer overview slideshow
Actor Michael Douglas